Leading the charge against a potential killer
In India, they stopped giving it after four deaths.
Here in the U.S., there’s a major push for broadening the market, despite the 71 deaths linked to the vaccine in VAERS (as of September 15), among those who have received it.
And in Australia, one woman is leading the charge against Gardasil.
She’s filing a class action suit against Merck following suffering an autoimmune and neurological attack after being injected with the vaccine. Other women who are thinking about joining say they’ve suffered anaphylaxis and physical breakdowns. One heartbroken woman says Gardasil caused her miscarriage.
The woman leading the charge says she had to put her life on hold for more than two years. She was unable to walk and was in horrible pain. She started suffering convulsions soon after her first injection. She’s seeking compensation for lost income and mounting medical expenses.
She didn’t suspect the vaccine at first. I mean, you trust your doctor, right? So she went back for a second…and for a third…dose. Her doctors at first said it was MS. But they’ve since re-labeled her ordeal a “neurological reaction” to the vaccine.
Meanwhile, the government in Australia continues to campaign for vaccinating all women between the ages of 12 and 26, going so far as to offer the course of shots free of charge.
Here in the U.S., of course, we’re looking at a potential double audience (and double profits for Merck). Recent research pushed the CDC to recommend that 11- and 12-year-old boys receive the vaccine to protect themselves as well as future sexual partners. When I say recent, I mean VERY recent–this research was published only this fall.
So, the CDC is lightning-fast in their reaction to positive research about Gardasil, but the very real concerns and reports about its dangers continue to go ignored. Meanwhile Merck continues to rake in the profits–sales have gone up 41 percent in the past year, and the success of Gardasil has caused the drug giant’s income to “surge,” according to the Financial Times.
Right now, I must admit that things look pretty bleak, as profits beat protecting the public, but I believe the truth will come out. The Australian lawsuit isn’t the first–and it won’t be the last.
“Class action on cancer vaccine Gardasil,” The Herald Sun (www.heraldsun.com.au)
“Health Buzz: Boys Should Get HPV Vaccine, Health Officials Say,” U.S. News Health (health.usnews.com)
“Reports of Health Concerns Following HPV Vaccination,” CDC (www.cdc.gov/)
“Merck earnings rise on HPV vaccine success,” Financial Times (www.ft.com/)